HEADER TRANSFERASE 17-FEB-22 7YY1 TITLE MYCOBACTERIUM ABSCESSUS PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE TERNARY TITLE 2 COMPLEX WITH 4'-PHOSPHOPANTETHEINE & NON-HYDROLYZABLE ATP ANALOGUE TITLE 3 (AMPCPP) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: DEPHOSPHO-COA PYROPHOSPHORYLASE,PANTETHEINE-PHOSPHATE COMPND 5 ADENYLYLTRANSFERASE,PPAT; COMPND 6 EC: 2.7.7.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTEROIDES ABSCESSUS; SOURCE 3 ORGANISM_TAXID: 36809; SOURCE 4 GENE: COAD, MAB_3259C; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS COAD, PPAT, NUCLEOTIDYLTRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.E.THOMAS,A.G.COYNE,T.L.BLUNDELL REVDAT 2 31-JAN-24 7YY1 1 REMARK REVDAT 1 29-JUN-22 7YY1 0 JRNL AUTH S.E.THOMAS,W.J.MCCARTHY,J.EL BAKALI,K.P.BROWN,S.Y.KIM, JRNL AUTH 2 M.BLASZCZYK,V.MENDES,C.ABELL,R.A.FLOTO,A.G.COYNE, JRNL AUTH 3 T.L.BLUNDELL JRNL TITL STRUCTURAL CHARACTERIZATION OF MYCOBACTERIUM ABSCESSUS JRNL TITL 2 PHOSPHOPANTETHEINE ADENYLYL TRANSFERASE LIGAND INTERACTIONS: JRNL TITL 3 IMPLICATIONS FOR FRAGMENT-BASED DRUG DESIGN. JRNL REF FRONT MOL BIOSCI V. 9 80432 2022 JRNL REFN ESSN 2296-889X JRNL PMID 35712348 JRNL DOI 10.3389/FMOLB.2022.880432 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.79 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 62124 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 3140 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 64.7870 - 4.7539 0.99 2836 175 0.1954 0.2056 REMARK 3 2 4.7539 - 3.7734 0.99 2700 167 0.1602 0.1872 REMARK 3 3 3.7734 - 3.2965 1.00 2752 126 0.1831 0.1962 REMARK 3 4 3.2965 - 2.9951 0.99 2712 129 0.1936 0.2475 REMARK 3 5 2.9951 - 2.7804 1.00 2675 180 0.2012 0.2019 REMARK 3 6 2.7804 - 2.6165 1.00 2682 137 0.1989 0.2485 REMARK 3 7 2.6165 - 2.4854 1.00 2719 150 0.2097 0.2183 REMARK 3 8 2.4854 - 2.3772 0.99 2660 122 0.2093 0.2416 REMARK 3 9 2.3772 - 2.2857 1.00 2691 131 0.2047 0.2393 REMARK 3 10 2.2857 - 2.2068 0.99 2708 134 0.2130 0.2509 REMARK 3 11 2.2068 - 2.1378 1.00 2689 133 0.2060 0.2409 REMARK 3 12 2.1378 - 2.0767 1.00 2714 118 0.2121 0.2709 REMARK 3 13 2.0767 - 2.0220 1.00 2655 137 0.2111 0.2647 REMARK 3 14 2.0220 - 1.9727 0.99 2650 155 0.2179 0.2634 REMARK 3 15 1.9727 - 1.9279 0.99 2614 160 0.2238 0.2404 REMARK 3 16 1.9279 - 1.8868 0.99 2678 148 0.2429 0.2574 REMARK 3 17 1.8868 - 1.8491 1.00 2648 155 0.2395 0.2787 REMARK 3 18 1.8491 - 1.8142 1.00 2657 157 0.2351 0.2854 REMARK 3 19 1.8142 - 1.7818 1.00 2652 145 0.2333 0.2859 REMARK 3 20 1.7818 - 1.7516 0.99 2674 131 0.2448 0.2543 REMARK 3 21 1.7516 - 1.7233 0.99 2654 123 0.2450 0.2930 REMARK 3 22 1.7233 - 1.6970 0.95 2564 127 0.2570 0.2887 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.180 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3921 REMARK 3 ANGLE : 1.137 5397 REMARK 3 CHIRALITY : 0.048 599 REMARK 3 PLANARITY : 0.005 669 REMARK 3 DIHEDRAL : 22.498 1579 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7YY1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1292121051. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-MAR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.17 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62224 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.697 REMARK 200 RESOLUTION RANGE LOW (A) : 64.790 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 8.600 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 8.30 REMARK 200 R MERGE FOR SHELL (I) : 1.29200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.7 REMARK 200 STARTING MODEL: 5O06 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.69 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM BROMIDE, 20-24 % PEG3350, REMARK 280 0.1 M BIS-TRIS PROPANE PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.34500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.34500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.82550 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 62.73750 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.82550 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 62.73750 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 59.34500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.82550 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 62.73750 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 59.34500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.82550 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 62.73750 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 23950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -206.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -59.34500 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 361 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 398 LIES ON A SPECIAL POSITION. REMARK 375 HOH C 318 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 0 REMARK 465 GLY A 158 REMARK 465 GLN A 159 REMARK 465 ALA A 160 REMARK 465 GLN A 161 REMARK 465 SER B 0 REMARK 465 GLY B 158 REMARK 465 GLN B 159 REMARK 465 ALA B 160 REMARK 465 GLN B 161 REMARK 465 SER C 0 REMARK 465 PRO C 39 REMARK 465 ASN C 40 REMARK 465 LYS C 41 REMARK 465 GLY C 158 REMARK 465 GLN C 159 REMARK 465 ALA C 160 REMARK 465 GLN C 161 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 1 CG SD CE REMARK 470 LYS A 41 CD CE NZ REMARK 470 ILE B 37 CG1 CG2 CD1 REMARK 470 ASN B 38 CG OD1 ND2 REMARK 470 ASN B 40 CG OD1 ND2 REMARK 470 LYS B 41 CG CD CE NZ REMARK 470 TYR B 97 OH REMARK 470 GLN B 150 CG CD OE1 NE2 REMARK 470 MET C 1 CG SD CE REMARK 470 LEU C 36 CD1 REMARK 470 ILE C 37 CG1 CG2 CD1 REMARK 470 ASN C 38 CG OD1 ND2 REMARK 470 GLU C 49 CG CD OE1 OE2 REMARK 470 GLU C 52 CG CD OE1 OE2 REMARK 470 ASP C 60 CG OD1 OD2 REMARK 470 TYR C 97 OH REMARK 470 VAL C 148 CG1 CG2 REMARK 470 GLN C 150 CG CD OE1 NE2 REMARK 470 LYS C 155 CG CD CE NZ REMARK 470 ARG C 157 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 96 CD GLU A 96 OE1 -0.071 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 83 16.87 -148.76 REMARK 500 ALA A 109 -1.48 -143.26 REMARK 500 ASN B 83 34.54 -151.42 REMARK 500 ALA B 109 -0.40 -149.55 REMARK 500 ASN C 83 35.01 -147.68 REMARK 500 ALA C 109 -2.39 -145.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 151 0.08 SIDE CHAIN REMARK 500 ARG B 78 0.15 SIDE CHAIN REMARK 500 ARG C 78 0.15 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 360 DISTANCE = 5.82 ANGSTROMS DBREF 7YY1 A 1 161 UNP B1MDL6 COAD_MYCA9 1 161 DBREF 7YY1 B 1 161 UNP B1MDL6 COAD_MYCA9 1 161 DBREF 7YY1 C 1 161 UNP B1MDL6 COAD_MYCA9 1 161 SEQADV 7YY1 SER A 0 UNP B1MDL6 EXPRESSION TAG SEQADV 7YY1 SER B 0 UNP B1MDL6 EXPRESSION TAG SEQADV 7YY1 SER C 0 UNP B1MDL6 EXPRESSION TAG SEQRES 1 A 162 SER MET THR GLY ALA VAL CYS PRO GLY SER PHE ASP PRO SEQRES 2 A 162 VAL THR LEU GLY HIS LEU ASP VAL PHE GLU ARG ALA ALA SEQRES 3 A 162 ALA GLN PHE ASP GLU VAL ILE VAL ALA VAL LEU ILE ASN SEQRES 4 A 162 PRO ASN LYS ALA GLY MET PHE THR VAL ASP GLU ARG ILE SEQRES 5 A 162 GLU MET ILE ARG GLU SER THR ALA ASP LEU PRO ASN LEU SEQRES 6 A 162 ARG VAL GLU SER GLY GLN GLY LEU LEU VAL ASP PHE VAL SEQRES 7 A 162 ARG GLU ARG GLY LEU ASN ALA ILE VAL LYS GLY LEU ARG SEQRES 8 A 162 THR GLY THR ASP PHE GLU TYR GLU LEU GLN MET ALA GLN SEQRES 9 A 162 MET ASN LYS HIS ILE ALA GLY VAL ASP THR PHE PHE VAL SEQRES 10 A 162 ALA THR ALA PRO ALA TYR SER PHE VAL SER SER SER LEU SEQRES 11 A 162 ALA LYS GLU VAL ALA THR TYR GLY GLY ASP VAL SER ALA SEQRES 12 A 162 LEU LEU PRO ALA SER VAL HIS GLN ARG LEU LEU GLY LYS SEQRES 13 A 162 LEU ARG GLY GLN ALA GLN SEQRES 1 B 162 SER MET THR GLY ALA VAL CYS PRO GLY SER PHE ASP PRO SEQRES 2 B 162 VAL THR LEU GLY HIS LEU ASP VAL PHE GLU ARG ALA ALA SEQRES 3 B 162 ALA GLN PHE ASP GLU VAL ILE VAL ALA VAL LEU ILE ASN SEQRES 4 B 162 PRO ASN LYS ALA GLY MET PHE THR VAL ASP GLU ARG ILE SEQRES 5 B 162 GLU MET ILE ARG GLU SER THR ALA ASP LEU PRO ASN LEU SEQRES 6 B 162 ARG VAL GLU SER GLY GLN GLY LEU LEU VAL ASP PHE VAL SEQRES 7 B 162 ARG GLU ARG GLY LEU ASN ALA ILE VAL LYS GLY LEU ARG SEQRES 8 B 162 THR GLY THR ASP PHE GLU TYR GLU LEU GLN MET ALA GLN SEQRES 9 B 162 MET ASN LYS HIS ILE ALA GLY VAL ASP THR PHE PHE VAL SEQRES 10 B 162 ALA THR ALA PRO ALA TYR SER PHE VAL SER SER SER LEU SEQRES 11 B 162 ALA LYS GLU VAL ALA THR TYR GLY GLY ASP VAL SER ALA SEQRES 12 B 162 LEU LEU PRO ALA SER VAL HIS GLN ARG LEU LEU GLY LYS SEQRES 13 B 162 LEU ARG GLY GLN ALA GLN SEQRES 1 C 162 SER MET THR GLY ALA VAL CYS PRO GLY SER PHE ASP PRO SEQRES 2 C 162 VAL THR LEU GLY HIS LEU ASP VAL PHE GLU ARG ALA ALA SEQRES 3 C 162 ALA GLN PHE ASP GLU VAL ILE VAL ALA VAL LEU ILE ASN SEQRES 4 C 162 PRO ASN LYS ALA GLY MET PHE THR VAL ASP GLU ARG ILE SEQRES 5 C 162 GLU MET ILE ARG GLU SER THR ALA ASP LEU PRO ASN LEU SEQRES 6 C 162 ARG VAL GLU SER GLY GLN GLY LEU LEU VAL ASP PHE VAL SEQRES 7 C 162 ARG GLU ARG GLY LEU ASN ALA ILE VAL LYS GLY LEU ARG SEQRES 8 C 162 THR GLY THR ASP PHE GLU TYR GLU LEU GLN MET ALA GLN SEQRES 9 C 162 MET ASN LYS HIS ILE ALA GLY VAL ASP THR PHE PHE VAL SEQRES 10 C 162 ALA THR ALA PRO ALA TYR SER PHE VAL SER SER SER LEU SEQRES 11 C 162 ALA LYS GLU VAL ALA THR TYR GLY GLY ASP VAL SER ALA SEQRES 12 C 162 LEU LEU PRO ALA SER VAL HIS GLN ARG LEU LEU GLY LYS SEQRES 13 C 162 LEU ARG GLY GLN ALA GLN HET PNS A 201 22 HET APC A 202 62 HET PNS B 201 22 HET APC B 202 62 HET PNS C 201 22 HET APC C 202 62 HETNAM PNS 4'-PHOSPHOPANTETHEINE HETNAM APC DIPHOSPHOMETHYLPHOSPHONIC ACID ADENOSYL ESTER HETSYN APC ALPHA,BETA-METHYLENEADENOSINE-5'-TRIPHOSPHATE FORMUL 4 PNS 3(C11 H23 N2 O7 P S) FORMUL 5 APC 3(C11 H18 N5 O12 P3) FORMUL 10 HOH *245(H2 O) HELIX 1 AA1 THR A 14 PHE A 28 1 15 HELIX 2 AA2 THR A 46 THR A 58 1 13 HELIX 3 AA3 LEU A 72 ARG A 80 1 9 HELIX 4 AA4 THR A 91 GLY A 110 1 20 HELIX 5 AA5 ALA A 119 SER A 123 5 5 HELIX 6 AA6 SER A 126 TYR A 136 1 11 HELIX 7 AA7 VAL A 140 LEU A 144 5 5 HELIX 8 AA8 PRO A 145 ARG A 157 1 13 HELIX 9 AA9 THR B 14 ALA B 26 1 13 HELIX 10 AB1 THR B 46 THR B 58 1 13 HELIX 11 AB2 LEU B 72 ARG B 80 1 9 HELIX 12 AB3 THR B 91 GLY B 110 1 20 HELIX 13 AB4 ALA B 119 SER B 123 5 5 HELIX 14 AB5 SER B 126 TYR B 136 1 11 HELIX 15 AB6 VAL B 140 LEU B 144 5 5 HELIX 16 AB7 PRO B 145 ARG B 157 1 13 HELIX 17 AB8 THR C 14 ALA C 26 1 13 HELIX 18 AB9 THR C 46 THR C 58 1 13 HELIX 19 AC1 LEU C 72 ARG C 80 1 9 HELIX 20 AC2 THR C 91 GLY C 110 1 20 HELIX 21 AC3 ALA C 119 SER C 123 5 5 HELIX 22 AC4 SER C 126 TYR C 136 1 11 HELIX 23 AC5 VAL C 140 LEU C 144 5 5 HELIX 24 AC6 PRO C 145 ARG C 157 1 13 SHEET 1 AA1 3 GLY A 3 GLY A 8 0 SHEET 2 AA1 3 GLU A 30 LEU A 36 1 O ILE A 32 N ALA A 4 SHEET 3 AA1 3 LEU A 64 GLY A 69 1 O ARG A 65 N VAL A 33 SHEET 1 AA2 2 ALA A 84 LEU A 89 0 SHEET 2 AA2 2 ASP A 112 ALA A 117 1 O PHE A 114 N ILE A 85 SHEET 1 AA3 3 GLY B 3 GLY B 8 0 SHEET 2 AA3 3 GLU B 30 LEU B 36 1 O LEU B 36 N GLY B 8 SHEET 3 AA3 3 LEU B 64 GLY B 69 1 O ARG B 65 N VAL B 33 SHEET 1 AA4 2 ALA B 84 LEU B 89 0 SHEET 2 AA4 2 ASP B 112 ALA B 117 1 O PHE B 114 N ILE B 85 SHEET 1 AA5 3 GLY C 3 GLY C 8 0 SHEET 2 AA5 3 GLU C 30 LEU C 36 1 O ILE C 32 N CYS C 6 SHEET 3 AA5 3 LEU C 64 GLY C 69 1 O ARG C 65 N VAL C 33 SHEET 1 AA6 2 ALA C 84 LEU C 89 0 SHEET 2 AA6 2 ASP C 112 ALA C 117 1 O PHE C 114 N ILE C 85 CISPEP 1 ASP A 11 PRO A 12 0 1.72 CISPEP 2 ASP B 11 PRO B 12 0 1.14 CISPEP 3 ASP C 11 PRO C 12 0 -3.16 CRYST1 75.651 125.475 118.690 90.00 90.00 90.00 C 2 2 21 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013219 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007970 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008425 0.00000